Once a shining star in the biotech landscape, 23andMe now faces a chaotic downfall. With its promising roots in genetic testing, the company grapples with financial struggles and shifting market dynamics, prompting a critical reevaluation of its future.
Read MoreIn a groundbreaking discovery, researchers unveil Chromosome X’s unexpected role in cognitive aging. This revelation opens new avenues for understanding how genetics influence our mental decline, challenging long-held assumptions about brain health and longevity.
Read More